0000899140-24-000673.txt : 20240625
0000899140-24-000673.hdr.sgml : 20240625
20240625161611
ACCESSION NUMBER: 0000899140-24-000673
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240623
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DONG-A ST CO., LTD
CENTRAL INDEX KEY: 0001799260
ORGANIZATION NAME:
STATE OF INCORPORATION: M5
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 241069156
BUSINESS ADDRESS:
STREET 1: 64, CHEONHO-DAERO
STREET 2: DONGDAEMUN-GU
CITY: SEOUL
STATE: M5
ZIP: 02587
BUSINESS PHONE: 82-2-920-8184
MAIL ADDRESS:
STREET 1: 64, CHEONHO-DAERO
STREET 2: DONGDAEMUN-GU
CITY: SEOUL
STATE: M5
ZIP: 02587
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
form4.xml
X0508
4
2024-06-23
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001799260
DONG-A ST CO., LTD
64, CHEONHO-DAERO
DONGDAEMUN-GU
SEOUL
M5
02587
KOREA, REPUBLIC OF
true
false
Common Stock
2024-06-23
4
P
0
2544530
3.13
A
5348229
D
Dong-A St Co., Ltd.; By: /s/ Min Young Kim, Chief Executive Officer
2024-06-25